Prevalence and patient awareness of selected potential drug interactions with self-medication

Journal of Clinical Pharmacy and Therapeutics

Volumn 32, Issue 2, 2007, Pages 149-159

  Indermitte, J ^a   Reber, D ^a   Beutler, M ^b   Bruppacher, R ^c   Hersberger, K E ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Medicines Commission of Swiss Pharmacists   (Switzerland)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Community pharmacy services; Drug interactions; Over the counter drugs; Patient awareness; Self medication

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CYCLOSPORIN; DEXTROMETHORPHAN; DICLOFENAC; DOXYCYCLINE; EPLERENONE; HYPERICUM PERFORATUM EXTRACT; IBUPROFEN; MIRTAZAPINE; MOCLOBEMIDE; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PHENPROCOUMON; PHENYLEPHRINE; POTASSIUM SALT; PSEUDOEPHEDRINE; RAPAMYCIN; SELEGILINE; TACROLIMUS; TRAMADOL;

ARTICLE; CARDIOVASCULAR DISEASE; CHI SQUARE TEST; CONFIDENCE INTERVAL; DATA BASE; DISEASE SEVERITY; DRUG MONITORING; FOOD DRUG INTERACTION; GRAPEFRUIT; HUMAN; LOW DRUG DOSE; PHARMACY; PRESCRIPTION; PREVALENCE; SELF MEDICATION; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; SWITZERLAND; TELEPHONE TELEMETRY;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICOAGULANTS; ASPIRIN; CLINICAL PHARMACY INFORMATION SYSTEMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERVIEWS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; PATIENT EDUCATION; PHARMACEUTICAL PREPARATIONS; PHARMACIES; PHARMACISTS; PROFESSIONAL ROLE; SELF MEDICATION; SODIUM CHANNEL BLOCKERS; TETRACYCLINES;

EID: 33947366868     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2007.00809.x     Document Type: Article

References (19)

1. Clark D, Layton D, Shakir SA (2001) Monitoring the safety of over the counter drugs. We need a better way than spontaneous reports. British Medical Journal, 323, 706-707.
2. Oborne CA, Luzac ML (2005) Over-the-counter medicine use prior to and during hospitalization. The Annals of Pharmacotherapy, 39, 268-273.
3. Sihvo S, Klaukka T, Martikainen J et al. (2000) Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population. European Journal of Clinical Pharmacology, 56, 495-499.
4. Hong SH, Spadaro D, West D et al. (2005) Patient valuation of pharmacist services for self care with OTC medications. Journal of Clinical Pharmacy and Therapeutics, 30, 193-199.
5. Glintborg B, Andersen SE, Spang-Hanssen E et al. (2004) The use of over-the-counter drugs among surgical and medical patients. European Journal of Clinical Pharmacology, 60, 431-437.
6. Covington TR (2002) The pharmacist as nonprescription drug therapy manager: let's seize the opportunity. Journal of the American Pharmacists Association (Washington), 42, 518-519.
7. Interpharma (2005) Pharma-Markt Schweiz, 12th edn. Basel: Interpharma.
8. Zehnder S, Beutler M, Bruppacher R et al. (2003) Drug information sources used by patients: a survey in Swiss community pharmacies with special focus on New Information Technologies. Journal of Social and Administrative Pharmacy, 20, 156-165.
9. Sinclair HK, Bond CM, Hannaford PC (2001) Long term follow-up studies of users of nonprescription medicines purchased from community pharmacies: some methodological issues. Drug Safety, 24, 929-938.
10. Kaufman DW, Kelly JP, Rosenberg L et al. (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. The Journal of the American Medical Association, 287, 337-344.
11. Bond C, Hannaford P (2003) Issues related to monitoring the safety of over-the-counter (OTC) medicines. Drug Safety, 26, 1065-1074.
12. Honig PK, Gillespie BK (1995) Drug interactions between prescribed and over-the-counter medication. Drug Safety, 13, 296-303.
13. Hansten PD, Horn JR (2005) Drug interactions: analysis and management. St Louis, MO: Facts and Comparisons.
14. Merlo J, Liedholm H, Lindblad U et al. (2001) Prescriptions with potential drug interactions dispensed at Swedish pharmacies in January 1999: cross sectional study. British Medical Journal, 323, 427-428.
15. E-mediat AG (2005) Schönbühl: Pharmavista®.
16. ABDA-Datenbank (2005) Werbe- und vertriebsgesellschaft deutscher apotheker mbH. Eschborn, Germany.
17. Wade AG (2002) Monitoring safety of over the counter drugs. Patients could do more than just treat themselves. British Medical Journal, 324, 424-425.
18. Hansten PD, Horn JR, Hazlet TK (2001) ORCA: OpeRational ClassificAtion of drug interactions. Journal of the American Pharmacists Association (Washington), 41, 161-165.
19. Bergk V, Gasse C, Rothenbacher D et al. (2004) Drug interactions in primary care: impact of a new algorithm on risk determination. Clinical Pharmacology and Therapeutics, 76, 85-96.